Brief: S2Medical To Receive Patent Approval For Instagraft Technology In Israel
Sept 9 (Reuters) - S2Medical AB S2ME.ST :
* INSTAGRAFT-PATENT APPROVED IN ISRAEL
* RECEIVED NOTICE THAT ISRAELI AUTHORITIES INTEND TO GRANT PATENT APPROVAL FOR COMPANY'S
INSTAGRAFT TECHNOLOGY IN ISRAEL.
Source text for Eikon: ID:nWkrT1gRm
Further company coverage: AZN.L
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on S2Medical AB (publ)
See all newsBrief: Eyracure Company Part-owned By S2Medical Files For Bankruptcy
Brief: S2Medical Plans Rights Issue To Raise SEK 2.9 Mln
Brief: S2medical H2 Net Sales At SEK 7.5 Mln
Brief: S2medical Signs Exclusive Distribution Agreement In UAE
Brief: S2Medical Validates European Patent For AMP Technology In 18 Countries